75 related articles for article (PubMed ID: 10193804)
1. Functional and structural properties of urinary tissue factor.
Lwaleed BA; Bass PS; Francis JL; Chisholm M
Nephrol Dial Transplant; 1999 Mar; 14(3):588-96. PubMed ID: 10193804
[TBL] [Abstract][Full Text] [Related]
2. Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury?
Lwaleed BA; Bass PS; Chisholm M; Francis JL
J Clin Pathol; 1997 Apr; 50(4):336-40. PubMed ID: 9215153
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
[TBL] [Abstract][Full Text] [Related]
4. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
5. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor assays as diagnostic tools for cancer? Correlation between urinary and monocyte tissue factor activity.
Lwaleed BA; Francis JL; Chisholm M
J Hematother Stem Cell Res; 1999 Dec; 8(6):659-68. PubMed ID: 10645774
[TBL] [Abstract][Full Text] [Related]
7. Effect of kidney function and disease status on urinary tissue factor measurements.
Lwaleed BA; Bass PS; Rogerson ME; Francis JL; Chisholm M
J Clin Pathol; 1998 Mar; 51(3):234-7. PubMed ID: 9659267
[TBL] [Abstract][Full Text] [Related]
8. Urinary tissue factor: a potential marker of disease.
Lwaleed BA; Bass PS; Francis JL
J Pathol; 1999 May; 188(1):3-8. PubMed ID: 10398132
[TBL] [Abstract][Full Text] [Related]
9. [Urinary level of tissue factor and its procoagulant activity in patients with type 2 diabetes].
Fu WJ; Zheng L; Wang Q; Deng RT; Ye CQ; Wang SB; Peng LF; Xiong SL; Tang HH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):878-81. PubMed ID: 21602148
[TBL] [Abstract][Full Text] [Related]
10. Localization of annexin V in rat normal kidney and experimental glomerulonephritis.
Matsuda R; Kaneko N; Horikawa Y; Chiwaki F; Shinozaki M; Ieiri T; Suzuki T; Ogawa N
Res Exp Med (Berl); 2001 Jan; 200(2):77-92. PubMed ID: 11271515
[TBL] [Abstract][Full Text] [Related]
11. Urinary tissue factor levels in neoplastic diseases.
Lwaleed BA; Francis JL; Chisholm M
Ann Saudi Med; 2000; 20(3-4):197-201. PubMed ID: 17322656
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor expression by a human kidney proximal tubular cell line in vitro: a model relevant to urinary tissue factor secretion in disease?
Lwaleed BA; Vayro S; Racusen LC; Cooper AJ
J Clin Pathol; 2007 Jul; 60(7):762-7. PubMed ID: 17158639
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an assay for urinary tissue factor activity.
Lwaleed BA; Chisholm M; Francis JL
J Clin Pathol; 1999 Mar; 52(3):219-24. PubMed ID: 10450183
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
[TBL] [Abstract][Full Text] [Related]
15. Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy.
Hisada Y; Auriemma AC; Alexander W; Ay C; Mackman N
Thromb Res; 2017 Feb; 150():65-72. PubMed ID: 28043041
[TBL] [Abstract][Full Text] [Related]
16. [Annexin A5 inhibits homocysteine-induced tissue factor expression and activity in vascular smooth muscle cells].
Li J; Chen T; Wang DM; Song YF; Hong M
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):1039-43. PubMed ID: 20137335
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
Erlich JH; Holdsworth SR; Tipping PG
Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
[TBL] [Abstract][Full Text] [Related]
18. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
[TBL] [Abstract][Full Text] [Related]
19. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA.
Tipping PG; Erlich JH; Apostolopoulos J; Mackman N; Loskutoff D; Holdsworth SR
Am J Pathol; 1995 Dec; 147(6):1736-48. PubMed ID: 7495298
[TBL] [Abstract][Full Text] [Related]
20. Deencryption of cellular tissue factor is independent of its cytoplasmic domain.
Wolberg AS; Kon RH; Monroe DM; Ezban M; Roberts HR; Hoffman M
Biochem Biophys Res Commun; 2000 Jun; 272(2):332-6. PubMed ID: 10833414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]